Target intelligence / Profile preview

Elongin C pseudogene 32 (ELOCP32)

Target: ELOCP32
Molecular classification: Other (Pseudogene)

Overview

Elongin C pseudogene 32 (ELOCP32, also known as TCEB1P32) is classified as a pseudogene related to elongin C, a component of the transcription elongation factor SIII. Pseudogenes are typically non-functional, do not produce protein, and are not considered molecular drug targets. There is currently no evidence linking ELOCP32 to specific biological functions, disease processes, or therapeutic applications.

Other names: TCEB1P32

Beyond the preview

Go deeper on Elongin C pseudogene 32 (ELOCP32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongin C pseudogene 32 (ELOCP32).

Explore the full profile